Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2025)

Cumberland Pharmaceuticals' Current Leases history spans 7 years, with the latest figure at $467774.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 31.21% year-over-year to $467774.0; the TTM value through Dec 2025 reached $467774.0, up 31.21%, while the annual FY2025 figure was $467774.0, 31.21% up from the prior year.
  • Current Leases for Q4 2025 was $467774.0 at Cumberland Pharmaceuticals, up from $401445.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.1 million in Q3 2021 and bottomed at $158369.0 in Q1 2023.
  • The 5-year median for Current Leases is $386077.0 (2025), against an average of $514855.2.
  • The largest annual shift saw Current Leases tumbled 82.17% in 2022 before it soared 128.73% in 2024.
  • A 5-year view of Current Leases shows it stood at $969677.0 in 2021, then crashed by 82.17% to $172910.0 in 2022, then skyrocketed by 93.33% to $334288.0 in 2023, then rose by 6.65% to $356508.0 in 2024, then soared by 31.21% to $467774.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Current Leases are $467774.0 (Q4 2025), $401445.0 (Q3 2025), and $386077.0 (Q2 2025).